Update from the GEMINI study programme – by Maria Dalby Jean-Frédéric Colombel, Mount Sinai Hospital, New York, USA The GEMINI study programme is a large phase-3 clinical trial… read more.
Stopping drugs – by Maria Dalby Charles Lees (Edinburgh, UK) Medication constitutes a large part of the IBD exposome, and stopping drug treatment should be a therapeutic goal… read more.
Management of ulcerative colitis: putting patients at the centre – by Maria Dalby Iris Dotan (Tel Aviv Sourasky Medical Centre, Israel), Peter Irving (Guy’s and St Thomas’ NHS… read more.
ECCO-EFCCA Patient Guidelines – by Maria Dalby Marco Greco, Milan, Italy; Séverine Vermeire, University Hospital of Leuven, Belgium; Salvatore Leone, Palermo, Italy; Paolo Gionchetti, University of Bologna, Italy;… read more.
by Bruce Sylvester: Researchers report that Herceptin (trastuzamab) plus lapatinib can shrink breast cancer tumors in less than two weeks. The findings were reported in March at the… read more.
by Bruce Sylvester: In high income countries, loneliness and social isolation appear to increase the risk of stroke or coronary artery disease by about 30 per cent, researchers… read more.
by Bruce Sylvester: Smoking cessation treatment with varenicline and bupropion does increase serious neuropsychiatric side effects, researchers reported in The Lancet on April 22, 2016.
by Bruce Sylvester: Treatment with cardioselective beta-blockers appears to reduce the risk of exacerbations in chronic obstructive pulmonary disease (COPD), and it is especially effective in preventing COPD… read more.
by Bruce Sylvester: Treatment with clemastine fumarate, an over-the-counter antihistamine used for allergies and the common cold, has partially reversed damage to the visual system in people with… read more.
by Bruce Sylvester: Patients with grade 2 glioma who received radiation therapy plus PCV chemotherapy (procarbazine, lomustine and vincristine) have achieved longer progression-free survival and overall survival than… read more.
by Bruce Sylvester: Hyrdomorphone, a licensed pain medication, shows efficacy in treating chronic heroin addiction, researchers from the SALOME (the Study to Assess Longer-term Opioid Medication Effectiveness) trial… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
